文献速递消化道肿瘤与早癌消化内镜

内脏型肥胖是监测性结肠镜检查中结直肠腺瘤发生的危险因素

Visceral obesity as a risk factor for colorectal adenoma occurrence in surveillance colonoscopy.
PubMed 文献 · Gastrointest Endosc · 2018-03-03

该队列研究纳入2244名参与者,于2006至2007年入组并随访至2014年,其中1163人(51.8%)接受了随访结肠镜检查;在中位43个月内,592人(50.9%)发生结直肠腺瘤,新发腺瘤患病率为39.1%,复发腺瘤患病率为60.1%。多变量分析显示,内脏脂肪面积升高与新发腺瘤风险升高相关,体质指数和腰围升高与复发腺瘤风险升高相关。

要点

  • 内脏脂肪面积最高五分位组较最低五分位组的新发腺瘤风险升高,HR为2.16(95%CI 1.26-3.71)。
  • 内脏脂肪面积每增加1个标准差,新发腺瘤的HR为1.32(95%CI 1.10-1.60)。
  • 体质指数每增加1 kg/m2,复发腺瘤的HR为1.33(95%CI 1.18-1.46);腰围每增加1 cm,HR为1.04(95%CI 1.01-1.07)。

核心结论

  • 较高的内脏脂肪面积与新发腺瘤风险升高呈剂量依赖性相关,作为腹部肥胖替代标志物的体质指数和腰围升高与复发腺瘤风险升高相关。

研究设计与样本

  • 一项队列研究,纳入2006至2007年间的2244名参与者,依据基线结肠镜及组织病理学结果前瞻性随访至2014年。
  • 1163名参与者(51.8%)接受了随访结肠镜检查,其中509人(43.8%)归入正常队列,654人(56.2%)归入腺瘤队列。
  • 新发腺瘤组定义为基线结肠镜结果正常、随访结肠镜结果阳性者;复发腺瘤组定义为基线为腺瘤、随访结肠镜结果阳性者。

主要发现

  • 在中位43个月的随访期内,592名患者(50.9%)发生结直肠腺瘤,新发腺瘤患病率为39.1%,复发腺瘤患病率为60.1%。
  • 多变量分析中,内脏脂肪面积最高五分位组较最低五分位组的新发腺瘤HR为2.16(95%CI 1.26-3.71),内脏脂肪面积每增加1个标准差的HR为1.32(95%CI 1.10-1.60)。
  • 多变量分析中,体质指数每增加1 kg/m2的复发腺瘤HR为1.33(95%CI 1.18-1.46),腰围每增加1 cm的HR为1.04(95%CI 1.01-1.07)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The aim of this study was to examine the prospective association between visceral obesity and the incidence and recurrence of colorectal adenoma. METHODS: We conducted a cohort study involving 2244 participants between 2006 and 2007. The study participants were prospectively followed until 2014 according to the initial colonoscopy and histopathology findings. Incident and recurrent colorectal adenoma groups were defined as individuals with a positive follow-up colonoscopy result from the normal results and adenoma groups, respectively, at the baseline colonoscopy. RESULTS: Among the 1163 patients (51.8%) who received a follow-up colonoscopy, 509 (43.8%) and 654 (56.2%) were grouped into the normal and adenoma cohorts. Colorectal adenomas occurred in 592 patients (50.9%) during the median period of 43 months, with an incident adenoma prevalence of 39.1% and a recurrent adenoma prevalence of 60.1%. An increase in the visceral adipose tissue (VAT) area was associated with a higher incidence of adenoma (highest quintile vs lowest quintile of the VAT hazard ratios [HRs], 2.16; 95% confidence interval [CI], 1.26-3.71; HR 1.32 [per 1-standard deviation]; 95% CI, 1.10-1.60) in the multivariable analysis. Increases in body mass index and waist circumference were associated with recurrent adenomas (HR 1.33 [per 1 kg/m2], 95% CI, 1.18-1.46; HR 1.04 [per 1 cm], 95% CI, 1.01-1.07, respectively) in the multivariate analysis. CONCLUSION: A higher VAT area was dose-dependently associated with a higher risk of incident adenoma. Furthermore, increases in body mass index and waist circumference as surrogate markers of abdominal obesity were associated with a higher risk of recurrent adenoma.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Im JP, Kim D, Chung SJ, et al. Visceral obesity as a risk factor for colorectal adenoma occurrence in surveillance colonoscopy. Gastrointest Endosc. 2018. PMID: 29510147. doi:10.1016/j.gie.2018.02.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。